Chinese firm Sinovac 99% sure COVID-19 antibody will work: Report Kumar Jeetendra | May 30, 2020 Chinese biopharmaceutical organization Sinovac Biotech has said that it is 99% certain that their COVID-19 antibody will work. The organization arrived at stage 2 of the coronavirus antibody preliminary with in excess of 1000 volunteers taking part. The organization is in starter converses with hold stage 3 preliminaries – the last piece of the procedure …
Researchers create technique to assist disease transmission experts with mapping spread of COVID-19 Kumar Jeetendra | June 1, 2020 Rochester Institute of Technology researchers have built up a strategy they accept will help disease transmission specialists all the more proficiently foresee the spread of the COVID-19 pandemic. Their new examination, distributed in Physica D: Nonlinear Phenomena, diagrams an answer for the SIR pandemic model, which is regularly used to anticipate what number of individuals …
Russia to reveal its previously endorsed COVID-19 drug one week from now Kumar Jeetendra | June 2, 2020 Russia will begin giving its first medication affirmed to treat COVID-19 to patients one week from now, its state money related benefactor told Reuters, a move it expectations will ease strains on the wellbeing framework and speed an arrival to typical monetary life. Russian clinics can start giving the antiviral medication, which is enlisted under …
Coronavirus immunization will be prepared by December-end, says Chinese organization SinoPharm Kumar Jeetendra | August 19, 2020 The head of a major state-owned Chinese pharmaceutical company explained its coronavirus vaccine will be commercially available at the end of the year. Liu Jingzhen, ” the chairman of SinoPharm, advised that a Chinese Communist Party newspaper that the vaccine would cost less than 1,000 yuan ($140) and be awarded in two shots, 28 weeks …
Brazil eyes Covid antibody rollout in January: Minister Kumar Jeetendra | September 9, 2020 Brazil’s acting Health Minister Eduardo Pazuello stated on Tuesday that a COVID-19 vaccine could be rolled out for all Brazilians in January 2021. “We’re closing contracts with vaccine manufacturers and the forecast is that a vaccine will arrive for us starting in January next year and we will begin vaccinating everybody,” Eduardo Pazuello said in …
Vaccines may require regular updates as Covid develops, say researchers Kumar Jeetendra | March 27, 2021 A health worker checks the Covishied, a COVID-19 vaccine manufactured by Serum Institute of India, as she prepares to start vaccination against COVID-19 in Kathmandu, Nepal January 27, 2021. (Reuters/Navesh Chitrakar) Scientists have assessed the course of development of the novel coronavirus and predicted that COVID-19 vaccines currently in use across the world may need …
Provided more than 1 billion COVID-19 vaccine dose up until now: BioNTech Kumar Jeetendra | August 9, 2021 BioNTech and partner Pfizer have supplied more than one billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca, the German biotech group said on Monday. The supply tally, up from more than 700 million doses announced by the biotech firm in June, compares with AstraZeneca saying …
Wockhardt inks agreement to deliver, supply Sputnik vaccine to Dubai-based firm Kumar Jeetendra | August 13, 2021 Drug maker Wockhardt on Friday said it has inked a pact with Dubai-based Enso Healthcare and a subsidiary of Russian Direct Investment Fund (RDIF) for production and supply of COVID-19 vaccine Sputnik. The Mumbai-based firm has entered into an agreement with Enso and Human Vaccine LLC , a wholly owned unit of the management company of RDIF …
Pfizer starts investigation of oral drug for counteraction of COVID-19 Kumar Jeetendra | September 27, 2021 Pfizer Inc said on Monday it has started a mid-to-late-stage study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus. The company and its rivals, including U.S.-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG, have been racing to develop the …
